Pfizer Boosts Annual Profit Forecast Amid Cost-Reduction Strategies

Pfizer Inc. has adjusted its financial outlook for the year, increasing its profit estimates due to successful cost-saving measures compensating for stagnant sales growth.

Projected Earnings per Share

The pharmaceutical giant now anticipates adjusted earnings to fall within the range of $2.90 to $3.10 per share in 2025. This is a shift from their earlier prediction, which ranged from $2.80 to $3 per share.

Revenue Projections Remain Steady

Despite these changes in profit outlook, Pfizer has kept its revenue forecast intact, expecting to achieve between $61 billion and $64 billion for the year, according to a company announcement on Tuesday.